A SARS-CoV-2 peptide vaccine which elicits T-cell responses in mice but does not protect against infection or diseaseVictoria K. Baxter, Alex Rubinsteyn|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusMark T. Heise, Victoria K. Baxter|Research Square|2023Cited by 0